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IntrOductIOn
Radioprotectors are chemical components that can alleviate 
biological damage produced by ionizing radiation. The first 
evidence of agents that were used as radioprotectors to reduce 
harmful effect of radiation on the mammalian bodies dates back to 
several decades ago [1]. Radioprotectors can have a wide range 
of applications. For radiation technologists or those who may be 
subject of unwanted exposure to ionizing radiation, application of 
radioprotectors could be used with radiation protection purpose to 
effectively reduce biological side effects. In patients who undergo 
radiotherapy procedures as a treatment, absorption of high level 
of radiation may lead to post therapy complications in their blood, 
intestine and immunologic systems. Radioprotectors, here, may be 
used as an effective agent that could allow application of high dose 
to the tumour with minimum risk to normal tissues. Adverse effects 
of ionizing radiation in both groups, irradiated staff and treated 
patients with radiation, can be reduced using radioprotectors. 
Up till now, several attempts have been done to introduce and 
study components that exhibit radioprotective properties [2-7], 
none of which meet the ideal radioprotector requirements and 
act perfectly. Most of the radioprotectors have cysteine amino 
acid and cysteine amine in their structures that are capable of 
blocking performance of free radicals in the body, however a 
vast majority of effective radioprotectors are toxic and there are 
continuous researches conducting to introduce new suitable 
radioprotectors with respect to properties such as efficiency, 
toxicity, manufacturing costs and duration of stability. One of 
these substances with potential radioprotective properties is beta 
D-glucan. Beta D-glucan is a polysaccharide which acts as an 
immune system booster and may improve recovery of patients 
 
after radiation therapy [8,9]. This agent is shown to have a good 
antioxidant activity by scavenging of hydroxyl radical [10]. It is also 
reported that, beta glucan of Ganoderma lucidum have significant 
DNA repairing ability [11]. This chemical component can reinforce 
immune system and protect body against ionizing radiation [12]. 
Molecular structure and chain conformations of D-glucan is well 
studied using infrared spectroscopy, Nuclear Magnetic Resonance 
(NMR) and laser scattering [13]. It is shown that, D-glucan is 
composed of main chain of 1-3 beta D-glucan and side chain of 
1-6 beta-D glucopyranosyl, and can be extracted from mushroom, 
bacteria and plant [14,15]. Because of interesting properties of 
this component including anti-tumour and anti-osteoporosis 
effects, improvement of the immune system [13] and anti-infection 
properties [16,17], beta D-glucan, has drawn interest of researches 
as an effective radioprotector agent.
Similar to D-glucan, vitamin E is also known as anti-oxidant 
agent that can decrease radiation induced damage in vitro [18]. 
This agent is shown to reduce chromosomal aberrations as well 
as micronuclei in bone marrow of irradiated mouse with 1 Gy 
[19]. However, there is also evidence in which vitamin E has not 
protected chromosomes against X-ray photons [20].
Therefore, in current study we assessed radioprotectory effect 
of beta D-glucan, alone and in combination with vitamin E, on 
irradiated mice with gamma photons, using Dose Reduction 
Factor, Lethal Dose50/30 (LD50/30), Lethal Dose50/60 (LD50/60). 
MAtErIALS And MEtHOdS 
A total of 240 female mice were arranged in four, equal population, 
groups of control (C), treated with beta D-glucan (G), fed with 250 
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Introduction: It is shown that beta-D-glucan is an immunologic 
system booster with radioprotectory effects. Radioprotectors 
are chemical components that can alleviate biological damage 
produced by ionizing radiation.
Aim: This study was designed to investigate the synergistic 
radioprotectory effects of beta-D-glucan and vitamin E on 
irradiated mice with 60Co source.
Materials and Methods: A total of 240 female mice were 
arranged in four, equal population groups of control group (C), 
treated group with beta D-glucan (G), treated group with vitamin 
E (E), and treated group with both beta D-glucan and vitamin 
E (G+E). Each group was divided into three equal population 
groups of D6, D7 and D8 exposed to 60Co radiation with 
prescribed total body dose of 6, 7 and 8 Gray (Gy), respectively. 
After the exposure, the number of survived animals was counted 
by time, then Lethal Dose50/30 (LD50/30), Lethal Dose50/60 (LD50/60) 
and Dose Reduction Factor (DRF) were calculated in all groups 
and corresponding groups.
results: Based on the results of current study, treatment of 
the animals with vitamin E did not change values of LD50/30 
and LD50/60, in comparison to control group. LD50/30 and LD50/60 
of treated groups with beta D-glucan and beta D-glucan + 
vitamin E showed significant difference with those of control 
group (p<0.01). The DRF values in groups E, G and G + E, 
were calculated respectively as 1, 1.25 and 1.375 based on 
LD50/30, and respectively as 1, 1.17 and 1.33 based on LD50/60. 
While values of DRF in groups G and G + E showed significant 
difference in comparison to that of control group (p<0.01), but 
the difference between DRF of groups G and G + E was not 
significant (p=0.395).
conclusion: The findings of study obviously showed that, 
presence of beta D-glucan in the body of mice, during exposure 
to ionizing radiation, leads to DRF of higher than one, proving 
the radioprotectory effect of this agent. Also, we demonstrated 
that, while vitamin E had no radioprotectory effect on irradiated 
mice, beta D-glucan in combination with vitamin E increased 
resistance of mice against ionizing radiation.
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Based on the statistical analysis of the results;
•	 The	 difference	 of	 DRF	 in	 group	G	 in	 comparison	with	 group	
C was significant at both LD50/30 (p= 0.005) and LD50/60 (p= 
0.005).
•	 The	difference	of	DRF	in	group	E	in	comparison	with	group	C	was	
insignificant at both LD50/30 (p= 1.000) and LD50/60 (p=1.000).
•	 	The	difference	of	DRF	in	group	E	+	G	in	comparison	with	group	
C was significant at both LD50/30 (p≤ 0.001) and LD50/60 (p≤ 
0.001), but in comparison with group G it was insignificant at 
both LD50/30 (p=0.395) and LD50/60 (p=0.395).
According to [Table/Fig-6], in control group, LD50/30 and LD50/60 
are 8 and 6 Gy, respectively. Values of LD50/30 and LD50/60 in the 
group treated with vitamin E were same as that of control group, 
which indicate that vitamin E, alone, did not have effect on the 
animal resistance against ionizing radiation. For groups G and G 
+	E	of	animals,	we	observed	that,	at	the	end	of	30	days,	number	
of animals killed by radiation did not reached to the ratio of 50%, 
therefore, we had to increase radiation doses up to 9, 10 and 11 Gy. 
The LD50/30	values	for	group	G	and	group	G	+	E	was	found	10	Gy	
and 11 Gy, respectively. Both findings show significant difference 
with that of control group (p<0.001), which means that both beta 
D-glucan and combination of beta D-glucan with vitamin E has 
radioprotective effect on animals. Any difference between these 
two groups was not observed. Also, after exposure of animals of 
group	G	and	G	+	E	to	dose	of	6	Gy,	half	of	the	animals	did	not	die	
within the 60 days and it took 66 days to reach to this number. For 
these groups, LD50/60 was determined 7 Gy for group G and 8 Gy 
for	group	G	+	E,	both	were	significantly	higher	than	that	of	control	
group (p<0.005). 
mg/body-weight, treated with vitamin E (E), fed with 1 mg/body-
weight for one month, and treated with both beta D-glucan and 
vitamin	 E	 (G+E).	 Each	 group	was	 then	 divided	 into	 three	 equal	
population groups of D6, D7 and D8 exposed to 60Co radiation 
with prescribed total body dose of 6, 7 and 8 Gy, respectively.
To assess response of the animals to ionizing radiation, three 
quantities of LD50/30, LD50/60 and DRF were calculated for each 
of groups. LD50/30 is a dose of radiation that can kill half of the 
irradiated animals within 30 days. Similarly, LD50/60 refers to the dose 
of radiation that can kill half of the animals within 60 days. DRF is 
another quantity to describe the effectiveness of a radioprotector 
and is defined as the ratio of the dose required to cause death in 
the presence of the component divided by the dose required to 
create the same effect in the absence of component.
StAtIStIcAL AnALYSIS
The analysis of variance (Kruskal–Wallis test) was used for each 
dose under four treatments. A p-value of less than 0.05 was 
considered to be statistically significant. The SPSS for Windows 
software package (Release 22, SPSS Inc., Chicago, Illinois) was 
applied for the statistical analysis. 
rESuLtS 
Surviving rate of animals, after exposure to the radiation doses of 
6, 7 and 8 Gy, in control group and treated groups with vitamin E, 
beta	D-glucan	and	vitamin	E	+	beta	D-glucan	are	given	in	[Table/
Fig-1-4]. DRF of these groups, with respect to the LD50/30 and 
LD50/60, were also given in [Table/Fig-5]. In [Table/Fig-6], LD50/30 and 
LD50/60 of the control and treated groups are presented.
[table/Fig-1]: Survival percent in group C irradiated at 6, 7 and 8 Gy doses of 60Co over the 60 day follow up.
[table/Fig-2]: Survival percent in group E irradiated at 6, 7 and 8 Gy doses of 60Co over the 60 day follow up.
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properties of beta D-glucan was measured on mice, based on the 
tumour volume, Natural Killer (NK) and Lymphokine Activated Killer 
(LAK) [22]. It was shown in treated group with beta D-glucan, weight 
and survival rate of animals not just had significant difference with 
those of control group, but level of NK and LAK was also increased. 
In other similar study, it was reported that chronic treatment with 
beta D-glucan decreased growth rate of tumour [23]. The reason 
of increased radioprotectory effect after administration of beta 
D-glucan was mentioned the hematopoietic effect as a result of 
increase of leukocytes and lymphocytes. In another attempt, anti-
tumour effect of beta D-glucan in combination of vitamin C on 
breast and lung tumours was reported [24]. Authors of that study 
concluded that simultaneous presence of these two components 
as wells as anti-tumour effect of beta D-glucan had been the reason 
for that finding. Synergistic effect of beta D-glucan in combination 
of resveratrol on the immune system has also been reported in 
similar studies [25,26]. 
Of the main findings of current study was the synergistic effect 
of beta D-glucan in combination with vitamin E to increase body 
radioprotective capability, which is in a good agreement with 
previous	studies	 [21,26].	On	 the	other	hand,	DRF	of	group	G	+	
E was higher than that of group E, which means beta D-glucan 
increased radioprotective effect of vitamin E. However, DRF of 
group	G	+	E	was	not	significantly	higher	than	that	of	group	G.
Because of the effectiveness of beta D-glucan and its combination 
with vitamin E as a radioprotective agent, this component could be 
used in clinical context for the patients that, because of treatment 
operations, their immune systems have been weakened. However, 
dIScuSSIOn 
These finding was another evidence to confirm that, beta D-glucan 
and its combination with vitamin E exhibit radioprotective effect. 
Our results agree with previous findings in which radioprotective 
properties of beta-glucan on immune system of the body was 
studied [14,17,21]. In a study, anti-tumour and radioprotectory 
[table/Fig-3]: Survival percent in group G irradiated at 6, 7 and 8 Gy doses of 60Co over the 60 day follow up.
[table/Fig-4]:	Survival	percent	in	group	E	+	G	irradiated	at	6,	7	and	8	Gy	doses	of	60Co over the 60-day follow up.
[table/Fig-5]: Values of Dose Reduction Factor (DRF) for treated groups of E, G and 
E	+	G	with	respect	to	LD50/30 and LD50/60.
Group    ld50/30 (Gy) dRF ld50/60 (Gy) dRF
 Control (C) 8 - 6 -
 Vitamin E (E) 8 1 6 1
 Beta Glucan (G) 10 1.25 7 1.17
	Beta	D-Glucan	+	Vitamin	E	(G+E) 11 1.375 8 1.33
[table/Fig-6]: Values of LD50/30 and LD50/60 in control group and three treated 
groups.
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comprehensive studies are required to translate this compound 
from bench to beside. For this reason, we conducted another 
research project to assess effect of beta D-glucan in reduction 
of side effects of ionizing radiation on healthy tissues of patients 
undergoing radiation based therapy. Also, because of the positive 
effect of beta D-glucan on the immune system, another study was 
planned to evaluate the effect of this substance on mitigation of 
chemotherapy side effects.
LIMItAtIOn
In this attempt we used a fixed dose of beta D-glucan at 250 
mg/body weight that is a limitation to this study, therefore, it is 
recommended to assess a similar study at different doses of this 
component in order to reach to an optimum dose of beta D-glucan 
as a radioprotective agent in combination with vitamin E. 
cOncLuSIOn
The findings obviously demonstrated that, presence of beta 
D-glucan in the body of mice, during exposure to ionizing radiation, 
leads to DRF of higher than one, proving the radioprotectory 
effect of this agent. Also, we depicted that, while vitamin E had 
no radioprotectory effect on irradiated mice, beta D-glucan in 
combination with vitamin E increased resistance of mice against 
ionizing radiation.
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